Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$25.00 USD
-1.12 (-4.29%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $25.01 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$25.00 USD
-1.12 (-4.29%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $25.01 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum B VGM
Zacks News
DENTSPLY (XRAY) Q2 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
DENTSPLY (XRAY) reported adjusted earnings of 60 cents per share, which came above the Zacks Consensus Estimate by a penny and was higher than earnings of 65 cents in the year-ago quarter.
Will Dentsply (XRAY) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Dental Stocks to Top Earnings Estimates This Season
by Zacks Equity Research
On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.
Why Dentsply (XRAY) Could Beat Earnings Estimates Again
by Zacks Equity Research
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What's in the Cards for Humana (HUM) Stock in Q2 Earnings?
by Zacks Equity Research
Humana's (HUM) second quarter is likely to gain traction from solid individual Medicare Advantage membership growth.
Can R&D Focus Drive DENTSPLY SIRONA's (XRAY) Q2 Earnings?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) continued focus on research and development and strategic buyouts are likely to drive Q2 results.
Here's Why You Should Hold Onto DENTSPLY SIRONA Stock Now
by Zacks Equity Research
DENTSPLY SIRONA (XRAY) gains from its increasing focus on innovation while a lowered earnings guidance for 2018 raises concern.
DENTSPLY (XRAY) Down 11.8% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
DENTSPLY (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now
by Zacks Equity Research
A rapidly changing healthcare environment in the United States, sluggish first quarter, declining margins and foreign exchange headwinds continue to hurt DENTSPLY SIRONA (XRAY).
DENTSPLY (XRAY) Beats Q1 Earnings Estimates, Lowers View
by Zacks Equity Research
Strong performance in Europe and Rest of World boosts DENTAPLY's (XRAY) performance in Q1. However, a lowered guidance indicates looming concerns.
Can Overall Growth Drive Henry Schein's (HSIC) Q1 Earnings?
by Zacks Equity Research
Henry Schein (HSIC) likely to gain on strength across all business segments in Q1.
What's in Store for DENTSPLY (XRAY) This Earnings Season?
by Zacks Equity Research
DENTSPLY's (XRAY) CAD/CAM unit is likely to drive the top line in Q1. Product innovations and strong R&D prospects are also likely to drive growth.
Henry Schein Ties Up With Internet Brands to Boost Dental Arm
by Zacks Equity Research
Henry Schein (HSIC) banks on part of its strategic plan, digital dentistry. In this regard, its latest joint venture with Internet Brands buoys optimism.
New Strong Sell Stocks for April 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
DENTSPLY to Acquire OraMetrix, Boost CAD-CAM Dental Unit
by Zacks Equity Research
The acquisition of OraMetrix is likely to bolster DENTSPLY's (XRAY) dental business.
Dental Implant & Prosthetic Boom Puts Spotlight on 3 Stocks
by Gargi Seth
The dental market has outperformed the broader market in last ten years on the back of demand from both teenagers and adults.
Here's Why You Should Steer Clear of DENTSPLY (XRAY) for Now
by Zacks Equity Research
DENTSPLY SIRONA (XRAY) faces foreign exchange woes and chances of margin decline in the quarters ahead.
New Strong Sell Stocks for March 19th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Strong performance at Dental & Healthcare Consumables segment drives DENTSPLY's (XRAY) Q4 sales.
Patterson Companies (PDCO) Q3 Earnings: What's in Store?
by Zacks Equity Research
Diverse product portfolio and strong veterinary business prospects to drive Patterson Companies (PDCO) in Q3. However, sluggishness in the Dental-Supply segment is a woe.
Can Geographical Sales Aid DENTSPLY's (XRAY) Q4 Earnings?
by Zacks Equity Research
DENTSPLY (XRAY) anticipates lower regional sales to dent results in Q4. The company continues to focus on operational excellence.
Patterson Companies' (PDCO) Dental Segment Shows Weakness
by Zacks Equity Research
Changing healthcare environment in the United States, unfavorable price movements and competitive dental products industry are posing challenges for Patterson Companies, Inc. (PDCO).
Align Teams Up with Exocad to Expand in Digital Scanning
by Zacks Equity Research
Align's (ALGN) collaboration with CAD/CAM software provider, Exocad GmbH, is likely to integrate the Chairside CAD software into Align's iTero Element intraoral scanner.
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) renewed distribution deal will help the company gain market traction. However, forex woes remain a concern.
Align Technology-Glidewell Dental Deal to Boost iTero Uptake
by Zacks Equity Research
Align Technology (ALGN) progresses with deals to boost the Scanners and Services segment.